FFM
Fairmount Funds Management Portfolio holdings
AUM
$772M
This Quarter Return
+31.43%
1 Year Return
+35.05%
3 Year Return
+1,168.51%
5 Year Return
+1,432.11%
10 Year Return
–
AUM
$542M
AUM Growth
+$542M
(+24%)
Cap. Flow
+$39.1M
Cap. Flow
% of AUM
7.22%
Top 10 Holdings %
Top 10 Hldgs %
68.16%
Holding
28
New
1
Increased
9
Reduced
4
Closed
2
Top Buys
| 1 |
Axsome Therapeutics
AXSM
|
$42.6M |
| 2 |
VRNA
Verona Pharma
VRNA
|
$17.9M |
| 3 |
Terns Pharmaceuticals
TERN
|
$12.1M |
| 4 |
Viridian Therapeutics
VRDN
|
$8.73M |
| 5 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$7.73M |
Top Sells
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$30.5M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$13.4M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$10.1M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$8.99M |
| 5 |
Olema Pharmaceuticals
OLMA
|
$3.97M |
Sector Composition
| 1 | Healthcare | 100% |